Understanding the transformative impact of ICH E6(R3) guidelines on clinical trial oversight and quality management. Introduction In the ever-evolving landscape of clinical trials, the recent update to the ICH E6(R3) Good Clinical Practice (GCP) guidelines...
The implementation of the Windsor Framework on January 1, 2025, marked a significant regulatory milestone for the UK pharmaceutical industry, particularly in pharmacovigilance (PV). For the first time, the Medicines and Healthcare Products Regulatory Agency (MHRA)...
Navigating ICH E6(R3): A New Era for Clinical Trials
Insights and Compliance Strategies for Pharmacovigilance Under the Windsor Framework
ADAMAS Consulting Strengthens Resources in APAC
DIA 2025 Global Annual Meeting | Washington, DC
Come and meet ADAMAS Consulting at the RQA International QA Conference, Brighton